Please assess the completion status of the following clinical trial:

Trial Title: Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria~* Documented history of bronchial asthma, first diagnosed at least 6 months prior to the screening visit and currently being treated only with intermittent short-acting beta -agonist therapy by inhalation.~* Pre-bronchodilator FEV1 \>75% of predicted at screening.~* Non-smoker~* Demonstration of a positive reaction to at least one allergen from a battery of allergens (including house dust mite, grass pollen and cat hair on skin prick testing at screening, or within 12 months of study start.~* Have Asthmatic response~* Able and willing to give written informed consent to take part in the study.~* Available to complete all study measurements.~Exclusion criteria:~* History of cardiovascular disease~* Clinically significant abnormalities in safety laboratory analysis at screening including any subject who has greater than trace urine protein levels following urinalysis at screening.~* History of hayfever~* The subject has tested positive for hepatitis C antibody or hepatitis B surface antigen.~* The subject has tested positive for HIV antibodies.~* The subject has positive drugs of abuse test.~* Subjects weighing less than 50kg are to be excluded from participating in the study.~* The subject has participated in a study with a new molecular entity during the previous 3 months.~* History of being unable to tolerate or complete methacholine, and/or allergen challenge tests.~* There is a risk of non-compliance with study medication or study procedures.~* History of blood donation (450 mL) within 2 months of starting the clinical study.~* The subject regularly drinks more than 28 units of alcohol in a week if male, or 21 units per week if female. One unit of alcohol is defined as a medium (125 ml) glass of wine, half a pint (250 ml) of beer or one measure (24 ml) of spirits.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).